🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

London's FTSE 100 opens lower as AstraZeneca weighs

Published 06/08/2020, 03:17 PM
Updated 06/08/2020, 03:20 PM
© Reuters.
UK100
-
GILD
-
AZN
-
FTMC
-
FTNMX601010
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* FTSE 100 down 0.7%, FTSE 250 down 0.5%

June 8 (Reuters) - London's FTSE 100 index opened lower on
Monday, hurt by losses in AstraZeneca after a report that the
drugmaker approached Gilead Sciences for a potential merger and
a warning from an industry body about surging corporate debt.
The blue-chip FTSE 100 .FTSE was down 0.7%, as AstraZeneca
AZN.L fell 1.8% following a Bloomberg News report on Sunday of
a possible merger with U.S. rival Gilead GILD.O to form one
the world's largest drug companies. Finance industry body TheCityUK said over the weekend that
about a third of the debt being taken on by British companies
under the government's emergency coronavirus lending plans could
be unsustainable, raising the need for fresh capital from new
investors. The mid-cap FTSE 250 .FTMC fell 0.5%, while oil and gas
stocks .FTNMX0530 jumped 2.9%, supported by higher crude
prices.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.